Medizone International, Inc. (OTCMKTS:MZEI) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07
|
Submission of Matters to a Vote of Security Holders. |
On December 15, 2016, Medizone International, Inc. (the Company)
held its 2016 Annual Meeting of Stockholders (the Annual
Meeting). A total of 393,934,068 shares of the Companys common
stock were entitled to vote as of October 21, 2016, the record
date for the Annual Meeting, of which 304,812,552 were present in
person or by proxy at the Annual Meeting. The final results for
each of the matters submitted to a vote of stockholders at the
Annual Meeting are as follows:
Proposal No. 1: All of the nominees for director were
elected to serve for a one-year term expiring on the date of the
Companys 2017 Annual Meeting of Stockholders by the votes set
forth in the table below:
|
Nominee |
For |
Withheld |
Broker Non-Votes |
|||
|
Edwin G. Marshall |
157,143,117 |
33,055,919 |
114,613,516 |
|||
|
Michael E. Shannon |
180,345,746 |
9,853,290 |
114,613,516 |
|||
|
Daniel D. Hoyt |
163,543,935 |
26,655,101 |
114,613,516 |
|||
|
David A. Esposito |
188,172,333 |
2,026,703 |
114,613,516 |
|||
|
Vincent C. Caponi |
187,974,538 |
2,224,498 |
114,613,516 |
Proposal No. 2: The appointment of Tanner LLC as the Companys
independent registered public accounting firm for the fiscal year
ending on December 31, 2016 was ratified by the Companys
stockholders by the votes set forth in the table below:
|
For |
Against |
Abstain |
||
|
292,444,639 |
7,918,234 |
4,249,679 |
Proposal No. 3: The compensation of the Companys Named Executive
Officers as disclosed in the Companys Proxy Statement dated
November 11, 2016, was approved by the Companys stockholders on
an advisory, non-binding basis by the votes set forth in the
table below:
|
For |
Against |
Abstain |
Broker Non-Votes |
|||
|
151,235,741 |
33,681,595 |
5,281,700 |
114,613,516 |
Proposal No. 4: The frequency of holding future advisory votes on
the compensation of the Companys Named Executive Officers was
approved by the Companys stockholders on an advisory, non-binding
basis by the votes set forth in the table below:
|
One Year |
Two Years |
Three Years |
Abstain |
|||
|
52,255,287 |
6,636,949 |
121,557,749 |
9,749,050 |
Proposal No. 5: The Amendment to Articles of Incorporation to
increase the number of authorized shares of common stock to
500,000,000 shares was approved by the Companys stockholders
holding a majority of the issued and outstanding shares of common
stock of the Company by the votes set forth in the table below:
|
For |
Against |
Abstain |
||
|
274,608,878 |
27,436,404 |
2,767,270 |
Proposal No. 6: The adoption of the Medizone International, Inc.
2016 Equity Incentive Award Plan was adopted by the Companys
stockholders by the votes set forth in the table below:
|
For |
Against |
Abstain |
Broker Non-Votes |
|||
|
148,093,389 |
37,202,266 |
4,903,381 |
114,613,516 |
Proposal No. 7: The Stockholder Proposal to amend the Bylaws of
the Company to impose mandatory retirement at the age of 75 years
for non-employee directors was not approved by stockholders
holding a majority of the issued and outstanding shares of common
stock of the Company as set forth in the table below:
|
For |
Against |
Abstain |
Broker Non-Votes |
|||
|
70,105,476 |
117,893,801 |
2,199,753 |
114,613,516 |
Proposal No. 8: The Stockholder Proposal to amend the Articles of
Incorporation of the Company to rescind the authorization to
issue the remaining unissued preferred stock of the Company was
not approved by stockholders holding a majority of the issued and
outstanding shares of common stock of the Company as set forth in
the table below:
|
For |
Against |
Abstain |
Broker Non-Votes |
|||
|
39,919,750 |
135,925,378 |
14,353,908 |
114,613,516 |
About Medizone International, Inc. (OTCMKTS:MZEI)
Medizone International, Inc. is engaged in designing, manufacturing and selling a system using ozone in the disinfection of surgical and other medical treatment facilities and in other applications. The Company’s AsepticSure is an ozone-based technology, which is used for the purpose of decontaminating and disinfecting hospital surgical suites, emergency rooms, intensive care units and other enclosed spaces, such as gym locker rooms, laboratories and veterinary clinics. In the AsepticSure system, oxygen atoms are misted into the environment with a hydrogen peroxide vapor and the system’s formula creates Trioxidane. The Company is developing a variant of AsepticSure for governmental use with bio-terrorism countermeasures. AsepticSure has completed safety and preliminary operational trials. During the tests, AsepticSure has demonstrated a turnaround time of approximately 90 minutes for disinfection and reoccupation of the hospital rooms. Medizone International, Inc. (OTCMKTS:MZEI) Recent Trading Information
Medizone International, Inc. (OTCMKTS:MZEI) closed its last trading session down -0.020 at 0.120 with 39,639 shares trading hands.